Nektar Therapeutics (NASDAQ:NKTR)

13.07
Delayed Data
As of Feb 27
 +0.09 / +0.69%
Today’s Change
10.10
Today|||52-Week Range
17.53
-15.68%
Year-to-Date

Today’s Trading

Previous close12.98
Today’s open13.00
Day’s range12.75 - 13.37
Volume1,665,755
Average volume (3 months)980,107
Market cap$1.7B
Dividend yield--
Data as of 4:00pm ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)+6.67%
Earnings growth (this year)+69.13%
Earnings growth (next 5 years)+42.46%
Revenue growth (last year)+83.42%
P/E ratioNM
Price/Sales8.82
Price/Book--

Competitors

 Today’s
change
Today’s
% change
FGENFibroGen Inc+0.81+2.61%
ARIAARIAD Pharmaceutical...-0.04-0.49%
INCRINC Research Holding...-0.58-1.90%
PRAHPRA Health Sciences ...+0.03+0.10%
Data as of 4:00pm ET, 02/27/2015

Financials

Next reporting dateMay 6, 2015
EPS forecast (this quarter)$0.37
Annual revenue (last year)$148.9M
Annual profit (last year)-$162.0M
Net profit margin-108.79%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Class I Director
Howard W. Robin
Chief Financial Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account